NewAmsterdam Pharma
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 10 trials in this atlas.
- Organization
- In this atlas
Overview
Technical summary
Sponsor class industry. No ROR record matches the name exactly.
Trials at a glance
These figures count only the registry trials in this atlas that name NewAmsterdam Pharma as a sponsor: 10 trials, 10 as lead sponsor and 0 as collaborator.
Phase and status
| Phase | Active, not recruiting | Completed | All statuses |
|---|---|---|---|
| Phase 2 | 0 | 4 | 4 |
| Phase 3 | 3 | 3 | 6 |
| All phases | 3 | 7 | 10 |
Start year
| Start year | Trials |
|---|---|
| 2025 | 1 |
| 2024 | 2 |
| 2022 | 4 |
| 2021 | 3 |
Main conditions
Main countries
- United States
- Netherlands
- Czechia
- Georgia
- Japan
Roles
- Company
- Sponsor
Sector
Industry
The registry's words
Labels as the registry gives them, not rewritten.
- Sponsor name
- NewAmsterdam Pharma
- Sponsor class
- INDUSTRY
Record details
- Record id
cardio:org-newamsterdam-pharma- Content hash
f0b44816d6d7e667e99069727892bfe0c518f22a97840b9f1cb75cd31a8d799d